Impella

heart model with cardiologist
MedTech

J&J delivers 10-year Impella gains in severe heart attacks

Johnson & Johnson MedTech demonstrated that its Impella CP can help STEMI heart attack patients gain an additional 600 days of life, on average.
Conor Hale Sep 2, 2025 1:30pm
FDA

FDA opens use of J&J's Impella heart pumps to pediatric patients

Dec 12, 2024 2:30pm
heart model

J&J's Abiomed pump reduces deaths after widowmaker heart attacks

Apr 8, 2024 12:12pm
FDA

J&J's Abiomed lands FDA warning letter over Impella heart pumps

Oct 13, 2023 10:42am
JJ Abiomed Impella RP Flex

J&J's Abiomed updates labeling for certain Impella heart pumps

Aug 18, 2023 10:18am
heart model

Four deaths linked to collisions of Abiomed pumps, TAVR implants

Jul 31, 2023 10:55am